Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Vvax001 therapeutic cancer vaccine
BIOLOGICAL
2 trials
Sponsors
University Medical Center Groningen
Conditions
CIN 2/3
CIN3
Cervical Cancer
Cervical Intraepithelial Neoplasia
Cervical Intraepithelial Neoplasia Grade 3
HPV 16 Infection
Phase 1
Vvax001 Cancer Vaccine in (Pre) Malignant Cervical Lesions
Completed
NCT03141463
University Medical Center Groningen
Cervical Cancer, CIN 2/3
Start: 2017-01-13
End: 2017-11-28
Updated: 2018-05-03
Phase 2
Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II
NCT06015854
University Medical Center Groningen
Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3, CIN3 +1
Start: 2021-03-23
End: 2024-04-01
Target: 18
Updated: 2023-08-29